AzTrials
AzTrials

Diabetes Type 2REWinDNCT01790724

Regulating Efficacy and Wellness in Diabetes

A study testing Walking exercise in people with Diabetes Type 2 and Metabolic Syndrome, run by University of Illinois at Urbana-Champaign at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The propose of the study is to test the hypothesis that an eight week program consisting of walking exercise and social cognitive theory based group workshops will increase physical activity adherence six months later in older adults with type 2 diabetes or metabolic syndrome. Read more about this study

Who is it for?
Ages 50 to 75 yearsHealthy volunteers can take part
Conditions the study is for
Diabetes Type 2, Metabolic Syndrome
What is being tested?
Walking exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
125 participants
Where
1 siteUnited States
Study dates
Jan 2013to May 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 75 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • adults between the ages of 50-75 years
  • individuals diagnosed with type 2 diabetes or metabolic syndrome (presence of 3 of the 5 criteria)
  • physician consent to participate.

Who cannot join

  • below age 50 or above age 75 at the beginning of the intervention
  • exercising regularly more than twice per week for the last six months
  • diagnosis of type 1 diabetes mellitus
  • failing the Telephone Interview of Cognitive Status
  • inability to communicate in English

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Illinois at Urbana-Champaign

    Urbana, Illinois, 61801

Other trials in United States

About this study

Official title: Social Cognitive and Neuropsychological Influences on Physical Activity Behavior in Type II Diabetes

The propose of the study is to test the hypothesis that an eight week program consisting of walking exercise and social cognitive theory based group workshops will increase physical activity adherence six months later in older adults with type 2 diabetes or metabolic syndrome.

Being tested
Walking exercise
Medical subject headings
Diabetes Mellitus, Type 2, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Walking exerciseBehavioural

Study groups in NCT01790724
Study groupRoleWhat they receive
Walking exerciseExperimentalParticipants will be instructed in safe walking exercise. They will participate in an eight week, tapered, on-site program. Participants will also attend group workshops where they will learn self-regulatory skills such as goal-setting, self-monitoring, barrier trouble-shooting, rewarding, and relapse prevention and recovery.
Receives: Behavioral: Walking exercise
Metabolic health educationActive comparatorParticipants will complete an eight-week online metabolic health education course. Topics will include glucose control, insulin, weight management, nutrition, physical activity, eye/kidney/foot health, stress reduction, and doctor-patient communication.
Receives: Behavioral: Walking exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Physical Activity

    Change from baseline to month six in physical activity. Participants will wear an accelerometer to measure physical activity.

    Measured: Month 6

Secondary outcomes (5)
  1. Self-efficacy

    We will assess changes in self-efficacy by written questionnaires.

    Measured: Month 6

  2. Executive function

    Participants will complete a neuropsychological battery of tasks assessing memory, attention and decision-making at baseline and month six.

    Measured: Month 6

  3. Self-regulatory strategy use

    We will assess changes in self-regulatory strategy use by written questionnaires.

    Measured: Month 6

  4. Physical function

    We will conduct functional fitness testing including tests of balance, strength, mobility and flexibility at baseline and six months.

    Measured: Month 6

  5. Psychosocial outcomes

    We will assess changes in psychosocial function ( e.g. self-esteem; social support; anxiety) by written questionnaires.

    Measured: Month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2013 (estimated)
  2. Study startJan 2013
  3. Primary completionDec 2013
  4. Study completionMay 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
125 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01790724
Sponsor's protocol ID
13146
Other IDs
1F31AG042232-01A1
Acronym
REWinD
Status last verified
Feb 2017
First submitted
11 Feb 2013
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
No

Publications

  • Olson EA, Mullen SP, Raine LB, Kramer AF, Hillman CH, McAuley E. Integrated Social- and Neurocognitive Model of Physical Activity Behavior in Older Adults with Metabolic Disease. Ann Behav Med. 2017 Apr;51(2):272-281. doi: 10.1007/s12160-016-9850-4.

    PubMed 27844326

Questions about this trial

What is this clinical trial studying?

A study testing Walking exercise in people with Diabetes Type 2 and Metabolic Syndrome, run by University of Illinois at Urbana-Champaign at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Physical Activity (time frame: Month 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01790724, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017; AzTrials last refreshed its copy on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in